Cytolytic virus activation therapy for Epstein-Barr virus-driven tumors.
Wildeman MA, Novalic Z, Verkuijlen SA, Juwana H, Huitema AD, Tan IB, Middeldorp JM, de Boer JP, Greijer AE.
Wildeman MA, et al. Among authors: verkuijlen sa.
Clin Cancer Res. 2012 Sep 15;18(18):5061-70. doi: 10.1158/1078-0432.CCR-12-0574. Epub 2012 Jul 3.
Clin Cancer Res. 2012.
PMID: 22761471